Publications
- Prognostic factors of early second transurethral resection of non-muscle invasive bladder cancer - 10 years of experience of a referral center2022 | Second Faculty of Medicine
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | First Faculty of Medicine, Second Faculty of Medicine
- Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study2024 | Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | First Faculty of Medicine, Second Faculty of Medicine
- Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
- Transurethral resection of bladder cancer with or without fluorescence2023 | Second Faculty of Medicine
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum2022 | First Faculty of Medicine, Second Faculty of Medicine
- Re: Bladder Cancer Therapy Using a Conformationally Fluid Tumoricidal Peptide Complex Editorial Comment2022 | Second Faculty of Medicine
- Management of BCG failure in non-muscle-invasive bladder cancer - the present and the future2022 | Second Faculty of Medicine
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel2021 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...